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Abstract
Background: Gastrocolic fistula is a rare presentation of both benign and malignant diseases of
the gastrointestinal tract. Malignant gastrocolic fistula is most commonly associated with
adenocarcinoma of the transverse colon in the Western World. Despite radical approaches to
treatment, long-term survival is rarely documented.
Case presentation: We report a case of a 24-year-old woman who presented with the classic
triad of symptoms associated with gastrocolic fistula. Radical en-bloc  surgery and adjuvant
chemotherapy were performed. She is still alive ten years after treatment.
Conclusions:  Gastrocolic fistula is an uncommon presentation of adenocarcinoma of the
transverse colon. Radical en-bloc surgery with adjuvant chemotherapy may occasionally produce
long-term survival.
Background
Gastrocolic fistula is a rare complication of both benign
and malignant diseases of the gastrointestinal tract [1-6].
In the Western World, adenocarcinoma of the transverse
colon is the commonest cause of a fistulous connection
between the stomach and the colon with a reported inci-
dence of 0.3–0.4% in operated cases [3,4]. Despite radical
en-bloc surgery, these patients usually have a poor prog-
nosis [5,6]. Long-term survival for these patients is rarely
reported [5].
The authors report a 24-year-old woman who presented
with a gastrocolic fistula secondary to an adenocarcinoma
of the transverse colon and describe her treatment and
long-term follow up.
Case presentation
A 24-year-old woman presented to the surgical clinic with
epigastric pain, feculent vomiting and post-prandial diar-
rhoea of three months duration; she had lost over one
stone in weight. She was previously healthy and was not
taking any regular medications. There was no history of
peptic ulcer disease, inflammatory bowel disease, trauma
or previous abdominal surgery. She had been investigated
two years previously by a gastroenterologist for intermit-
tent left-sided abdominal pain at which time the clinical
examination and blood tests were normal. Irritable bowel
syndrome had been diagnosed, although no colonic
imaging was performed. Both her maternal grandfather
and great-grandfather had suffered from colonic cancer.
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An initial ultrasound scan of the abdomen revealed thick-
ened bowel in the right upper quadrant with a dilated
duodenum. A barium meal and follow through was then
performed: this demonstrated a mucosal abnormality on
the greater curvature of the stomach with a fistulous tract
into the transverse colon (Figure 1). Barium enema and
colonoscopy were not performed. The presence of a
mucosal abnormality on the greater curvature of the stom-
ach was confirmed on upper gastrointestinal endoscopy
although initial biopsies revealed no evidence of a malig-
nant neoplasm. Her blood tests revealed: haemoglobin
9.5 g/dl, mean cell volume 71.6 fl and a white cell count
20.2 × 109/l; urea, electrolytes and liver function tests were
all normal.
In view of her symptoms, an exploratory laparotomy was
undertaken. At surgery, a large mobile tumour of the dis-
tal transverse colon was identified; this was adherent to
the greater curvature of the stomach, the mesentery and to
several loops of jejunum. A radical en-bloc resection was
performed involving a subtotal gastrectomy, transverse
colectomy and small bowel resection (Figure 2). The
patient made an uneventful recovery from surgery. Histol-
ogy revealed a poorly differentiated mucinous adenocarci-
noma of colon without lymphatic involvement (Dukes'
Stage B): this was adherent to and had penetrated the
stomach wall. She received adjuvant 5-fluorouracil (420
mg/m2) and folinic acid (20 mg/m2) chemotherapy every
four weeks for the following six months.
She has been followed-up with two-yearly colonoscopy
and five-yearly upper gastrointestinal endoscopy. She
remains well with no signs of either local or distant recur-
rence more than ten years after initial diagnosis.
Discussion
Advanced neoplasms of the stomach and transverse colon
are the commonest causes of a gastrocolic fistula: adeno-
carcinoma of the transverse colon is commoner in the
Western World [1,3,4], whereas adenocarcinoma of the
stomach is a more frequent cause in Japan [5]. Gastrocolic
fistula has also been reported with other tumour types
such as gastric lymphoma [7], carcinoid tumours of the
colon [8] and rarely, metastatic tumours [9] and infiltrat-
ing tumours of the pancreas, duodenum and biliary tract
[3]. With advances in medical treatment, gastrocolic fis-
tula secondary to peptic ulcer disease is now less common
[6]. A variety of other causes of gastrocolic fistula have
been reported: these include syphilis, tuberculosis,
abdominal trauma, Crohn's disease, Cytomegalovirus
gastric infection in AIDS patients and percutaneous endo-
scopic gastrostomy (PEG) tubes [10-13].
The fistulous connection in a gastrocolic fistula usually
arises between the greater curvature of the stomach and
the distal half of the transverse colon because of their
close anatomical proximity separated only by the gastro-
colic omentum [13]. Two theories have been advanced for
the development of a fistula [1,3,4]: the tumour may
invade directly across the gastrocolic omentum from the
orginating organ; alternatively, a tumour ulcer may pro-
voke a surrounding inflammatory peritoneal reaction
leading to the adherence and fistulation between the two
organs. Cases of malignant gastrocolic fistula have usually
been characterised by the presence of large infiltrative
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tumours with a surrounding inflammatory reaction, as
seen in our patient; lymph node involvement is unusual
[13].
Our patient presented with the characteristic triad of
symptoms associated with a gastrocolic fistula [5,14]:
diarrhoea, weight loss and faeculent vomiting. Other
symptoms include: abdominal pain, fatigue, faeculent
eructations and nutritional deficiencies. The gastrocolic
fistula was identified in our patient by means of an upper
gastrointestinal contrast series. Because the flow in the fis-
tula is predominantly from transverse colon to stomach
[15], several authors have suggested that barium enema is
the more sensitive investigation in detecting and delineat-
ing such a fistula, although the detection rate may be
lower in neoplastic cases [2,16-18]. Computerised tomog-
raphy may also be useful in both delineating the fistula
and identifying the underlying aetiology [5,19]. Endos-
copy is an excellent tool for visualising the fistulous open-
ing (especially in the stomach) and also allows
preoperative histological confirmation [20,21].
Although two stage approaches have been advocated his-
torically for malignant gastrocolic fistula, in order to first
correct nutritional deficiencies [22], most authors now
prefer radical en-bloc resections [14]. Despite such
approaches, most patients have a poor prognosis and no
patient has survived for more than nine years after resec-
tion [5]. This case report describes the longest disease free
survival of a patient with a malignant gastrocolic fistula.
To the authors' knowledge, she is also the youngest
patient to be reported. It is worth noting that colorectal
cancer in patients aged less than 35 years is normally asso-
ciated with a poorer prognosis compared with older age
groups [23-25]. This is related to the biological character-
istics of such tumours with a higher proportion of muci-
nous poorly differentiated tumours. As a result, younger
patients present with more advanced disease. Such
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patients require early diagnosis and a radical approach to
treatment.
Conclusions
Gastrocolic fistula is an uncommon presentation of aden-
ocarcinoma of the transverse colon. Radical en-bloc sur-
gery with adjuvant chemotherapy may occasionally
produce long-term survival.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
MJF  collated the information, searched literature and
wrote the manuscript.
JKD  assisted in literature search and writing of the
manuscript.
KM was responsible for long-term follow up of the patient
and assisted in literature search.
MCP managed the patient, helped in preparing the man-
uscript and edited the final version.
All authors have read and approved the final version of
the manuscript.
Acknowledgements
Written consent was obtained from the patient for publication of the case 
report.
References
1. Schweitzer RJ, Osborne MP: Gastrocolic fistula complicating
carcinoma; report of case due to carcinoma of colon, with
successful resection. Am J Surg 1953, 85:775-779.
2. Lahey FH, Swinton NW: Gastrojejunal ulcer and gastrojejuno-
colic fistula. Surg Gynecol Obstet 1935, 61:599-612.
3. Marshall SF, Knud-Hansen J: Gastrojejunocolic and gastrocolic
fistulas. Ann Surg 1957, 145:770-782.
4. Amlicke JA, Ponka JL: Gastrocolic and gastrojejunocolic fistulas.
A report of sixteen cases. Am J Surg 1964, 107:744-750.
5. Matsuo S, Eto T, Ohara O, Miyazaki J, Tsunoda T, Kanematsu T: Gas-
trocolic fistula originating from transverse colon cancer:
report of a case and review of the Japanese literature. Surg
Today 1994, 24:1085-1089.
6. Christiansen S, Sachatello C, Griffin WO Jr: Management of gas-
trocolic fistula. Am Surg 1981, 47:63-66.
7. Oh PI, Zalev AH, Colapinto ND, Deodhare SS, Brandwein J, Warren
RE:  Gastrocolic fistula secondary to primary gastric
lymphoma. J Clin Gastroenterol 1995, 20:45-48.
8. Lynch RC, Boese HL: Carcinoid tumor of transverse colon
complicated by gastrocolic fistula: survival following
resection. Surgery 1955, 38:600-604.
9. Chiang JM, Wang JY: Gastrocolic fistula due to a metastatic
marginal ulcer from carcinoma of the cervix. Int J Gynaecol
Obstet 1994, 47:173-174.
10. Aqel NM, Tanner P, Drury A, Francis ND, Henry K: Cytomegalovi-
rus gastritis with perforation and gastrocolic fistula
formation. Histopathology 1991, 18:165-168.
11. Greenstein AJ: Surgery for Crohn's disease. Surg Clin North Am
1987, 67:573-596.
12. Murphy S, Pulliam TJ, Lindsay J: Delayed gastrocolic fistula follow-
ing endoscopic gastrotomy. J Am Geriatr Soc 1991, 39:532-537.
13. Mallaiah L, Brozinsky S, Fruchter G, Siraj Uddin M: Malignant gas-
trocolic fistula case report and review of the literature. Am J
Proctol Gastroenterol Colon Rectal Surg 1980, 31:12-17.
14. Singh V, Wadleigh R: Gastrocolic fistula as a complication of
colonic carcinoma. Acta Oncologica 1997, 36:817-818.
15. Mathewson C Jr: Preliminary colostomy in the management of
gastrocolic and gastrojejunocolic fistula.  Ann Surg 1941,
114:1004-1010.
16. Skoog-Smith AW, Jaspin G, Sullivan JV: Gastrojejunocolic fistulas
: postoperative complications in 19 cases. Surg Gynecol Obstet
1950, 91:447-454.
17. Localio SA, Stone P, Hinton JW: Gastrojejunocolic fistula. Surg
Gynecol Obstet 1953, 96:455-462.
18. Lowdon AGR: Gastrojejunocolic fistula.  Br J Surg 1953,
41:113-128.
19. Lee WJ, Horton KM, Fishman EK: Gastrocolic fistula due to ade-
nocarcinoma of the colon: simulation of primary gastric lei-
omyosarcoma on CT. Clin Imaging 1999, 23:295-297.
20. Choi SW, Yang JM, Kim SS, Kang SH, Ro HJ, Song KS, Ha HK, Lim
KW, Kim JS: A case of combined gastrojejunal and gastrocolic
fistula secondary to gastric cancer.  J Korean Med Sci 1996,
11:437-439.
21. Mimidis K, Papadopoulos V, Katsinelos P, Deftereos S, Filippou D,
Kartalis G: Gastrocolic fistula secondary to nonsteroidal anti-
inflammatory drugs abuse in a cirrhotic patient.  Rom J
Gastroenterol 2004, 13:39-41.
22. Lorenzo GA, Beal JM: Gastrocolic fistula.  Am J Surg 1968,
115:724-726.
23. Taylor MC, Pounder D, Ali-Ridha NH, Bodurtha A, MacMullin EC:
Prognostic factors in colorectal carcinoma of young adults.
Can J Surg 1988, 31:150-153.
24. Cusack JC, Giacco GG, Cleary K, Davidson BS, Izzo F, Skibber J, Yen
J, Curley SA: Survival factors in 186 patients younger than 40
years old with colorectal adenocarcinoma. J Am Coll Surg 1996,
183:105-112.
25. Adkins RB Jr, DeLozier JB, McKnight WG, Waterhouse G: Carci-
noma of the colon in patients 35 years of age and younger.
Am Surg 1987, 53:141-145.